Balanced news tone
News Sentiment
TDAC sentiment intelligence
Translational Development Acquisition Corp. Ordinary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
90/100 classification confidence.
directly relevant articles
high-authority source matches
+0.1% over one week, -0.4% over four weeks, trend active, and near fair-value range.
Wolverine Asset Management (TDAC) reports 4.89% stake in Class A shares
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
US Financial Stocks Positioned for Higher Rates and Faster Earnings Growth
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 18 Jul 2026 07:43
- Source
- simplywall.st
Wolverine Asset Management (TDAC) reports 4.89% stake in Class A shares
Wolverine Asset Management, LLC, along with Wolverine Holdings, LLC, Christopher L. Gust, and Robert R. Bellick, have reported a beneficial ownership of 944,878 Class A Ordinary Shares in Translational Development Acquisition Corp. (TDAC). This represents a 4.89% stake in the com
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 16 Jul 2026 17:40
- Source
- Stock Titan
Price to sales forward of Translational Development Acquisition Corp. – NASDAQ:TDAC
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 11 Jul 2026 09:17
- Source
- TradingView
ProLogium–TDAC (NYSE: TDAC) merger advances with initial Form F-4 filing
Translational Development Acquisition Corp. (TDAC) announced that its merger partner, ProLogium Holding Inc., has filed an initial Registration Statement on Form F-4 with the SEC. This filing is a crucial step in the de-SPAC process for their business combination, originally anno
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Jul 2026 11:39
- Source
- Stock Titan
ProLogium files F-4 with SEC for TDAC merger transaction By Investing.com
ProLogium has filed an initial F-4 registration statement with the SEC for its de-SPAC merger transaction with Translational Development Acquisition Company (TDAC). The filing details ProLogium's history and the merger, which values ProLogium at approximately $3.8 billion. TDAC s
- Tone
- Positive 62/100
- Event
- Deals and strategy
- Published
- 06 Jul 2026 21:11
- Source
- Investing.com South Africa
ProLogium files F-4 with SEC for TDAC merger transaction
ProLogium has filed an initial F-4 registration statement with the SEC for its de-SPAC merger transaction with Translational Development Acquisition Company (TDAC). This filing provides detailed information about ProLogium's business and the merger, which values ProLogium at appr
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 06 Jul 2026 14:41
- Source
- Investing.com
TDAC (Translational Development Acquisition Corp) Holds Near Support After Slight Dip - Percent Above MA
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 02 Jul 2026 07:00
- Source
- dars.gov.et
Translational Development Acquisition Corp. (TDAC) Hovers Near NAV as SPAC Trades in Tight Range - Trend Continuation Trade
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 01 Jul 2026 07:00
- Source
- dars.gov.et
Form 8K Translational Development Unit For: 23 June By Investing.com
This article from Investing.com announces the filing of a Form 8K by Translational Development Unit for June 23. The piece is very short, primarily serving as an announcement, and provides minimal detail beyond the filing itself. It also includes market data for various financial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 07:40
- Source
- Investing.com South Africa
TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote
Translational Development Acquisition Company (TDAC) announced successful results for its shareholder vote regarding a SPAC life extension and share redemptions. Approximately 85% of shares were not redeemed, leaving $156.8 million in the trust account, and 95% of votes supported
- Tone
- Positive 72/100
- Event
- Deals and strategy
- Published
- 24 Jun 2026 09:10
- Source
- Morningstar
TDAC Shareholders Back ProLogium Merger Extension, Retaining $156.8M in Trust and 85% Share Support
Translational Development Acquisition Company (TDAC) shareholders have strongly supported extending their SPAC's life and the pending merger with ProLogium, a leader in lithium ceramic battery technology. A significant 85% of public shares were not redeemed, leaving approximately
- Tone
- Positive 70/100
- Event
- Deals and strategy
- Published
- 23 Jun 2026 15:14
- Source
- Minichart
Translational Development (TDAC) files redemption update on ProLogium deal (TDAC)
Translational Development Acquisition Corp. (TDAC) has filed a press release (Exhibit 99.1) detailing the results of shareholder redemptions related to a June 17, 2026 vote to extend the deadline for its initial business combination. The filing also provides information about TDA
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 23 Jun 2026 14:21
- Source
- Stock Titan
TDAC (NYSE: TDAC) retains $156.8mm in trust as most holders stay
Translational Development Acquisition Corp. (TDAC) announced that it retained $156.8 million in its trust account after 85% of shareholders chose not to redeem their shares, despite 2,598,697 Class A shares being redeemed. This outcome is considered a strong show of support for i
- Tone
- Positive 72/100
- Event
- Deals and strategy
- Published
- 23 Jun 2026 14:19
- Source
- Stock Titan
TDAC retains $156.8 million in trust as 85% reject redemption By Investing.com
Translational Development Acquisition Company (TDAC) announced that 85% of its shareholders opted not to redeem their shares, leaving approximately $156.8 million in the trust account. This decision, made after a vote on a SPAC timeline extension, reflects investor confidence in
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 22 Jun 2026 15:09
- Source
- Investing.com South Africa
TDAC retains $156.8 million in trust as 85% reject redemption
Translational Development Acquisition Company (TDAC) announced that 85% of its shareholders opted not to redeem their shares, retaining approximately $156.8 million in the company's trust account. This decision follows a vote on an extension of the SPAC’s timeline and reflects in
- Tone
- Positive 70/100
- Event
- Deals and strategy
- Published
- 22 Jun 2026 11:39
- Source
- Investing.com
Translational Development Acquisition Corp. (TDAC) Holds Steady at $10.75 as SPAC Trading Remains Range-Bound - Volatility Stop
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 22 Jun 2026 07:00
- Source
- dars.gov.et
Translational Development Acquisition shareholders approve extension for business combination
Translational Development Acquisition Corp. (NASDAQ: TDAC) shareholders have approved charter amendments to extend the deadline for completing an initial business combination by up to twelve months, to June 24, 2027. The extension allows for one-month increments, with the company
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 20 Jun 2026 04:10
- Source
- Investing.com Australia
Translational Development Acquisition shareholders approve extension for business combination By Investing.com
Shareholders of Translational Development Acquisition Corp. (NASDAQ:TDAC) have approved an extension to the deadline for completing an initial business combination, allowing the company up to twelve additional months until June 24, 2027. This decision, made at an extraordinary ge
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 19 Jun 2026 02:10
- Source
- Investing.com South Africa
TDAC (NASDAQ: TDAC) wins shareholder approval to extend SPAC deal deadline to 2027
Translational Development Acquisition Corp. (TDAC) has secured shareholder approval to extend its business combination deadline from June 24, 2026, to June 24, 2027, through a series of twelve one-month extensions. Each extension requires a deposit into the trust account, and whi
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 18 Jun 2026 13:09
- Source
- Stock Titan
TDAC (NASDAQ: TDAC) converts 4.66M sponsor Class B shares into Class A stock
Translational Development Acquisition Corp. (TDAC) has converted 4.66 million Class B ordinary shares held by its sponsor into an equal number of Class A ordinary shares. This conversion, which occurred on June 12, 2026, did not generate cash for the company nor alter the trust a
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 12 Jun 2026 19:39
- Source
- Stock Titan
ProLogium details tech, 800k cells shipped and TDAC tie‑up (TDAC)
Prologium Holding Inc. provided a strategic investor presentation detailing its superfluidized all-inorganic solid-state lithium ceramic battery technology, manufacturing scale-up plans, and proposed business combination with Translational Development Acquisition Corp. (TDAC). Th
- Tone
- Positive 63/100
- Event
- Deals and strategy
- Published
- 03 Jun 2026 20:40
- Source
- Stock Titan
Linden Advisors/Linden GP disclose 950,000-share stake in TDAC (TDAC)
Linden Advisors and Linden GP have disclosed a 950,000-share stake in Translational Development Acquisition Corp. (TDAC), representing approximately 5.5% of the outstanding Class A Ordinary Shares. This beneficial ownership includes shares held by Linden Capital and separate Mana
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 02 Jun 2026 18:40
- Source
- Stock Titan
ProLogium Set for Nasdaq Debut in $3.8 Billion SPAC Deal
Prologium, a Taiwan-based solid-state battery developer, plans to go public on Nasdaq through a $3.8 billion SPAC merger with Translational Development Acquisition Corp. The deal will provide capital for Prologium's growth, including the construction of a large-scale gigafactory
- Tone
- Positive 71/100
- Event
- Deals and strategy
- Published
- 01 Jun 2026 20:09
- Source
- Electric Cars Report
ProLogium, a Next Generation Solid-State Battery Developer with 10+ Years of Proven Commercialization, to List on the Nasdaq through a Merger with Translational Development Acquisition Corp.
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 27 May 2026 11:00
- Source
- GlobeNewswire
Translational Development Acquisition to Merge With ProLogium in SPAC Deal Valuing Target at $3.8 Billion
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 27 May 2026 07:00
- Source
- TradingView
ProLogium to list on Nasdaq via TDAC merger at $3.8B valuation
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 27 May 2026 07:00
- Source
- Seeking Alpha
Prologium Holdings Inc. agreed to acquire Translational Development Acquisition Corp. (NasdaqGM:TDAC.U) from TDAC Partners LLC for approximately $3.8 billion in a reverse merger transaction.
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 27 May 2026 07:00
- Source
- marketscreener.com
Prudential Earnings: Headline Numbers Make the Market Skeptical; Shares Fairly Valued
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Mar 2026 07:00
- Source
- Morningstar
TDAC Stock Price and Chart — NASDAQ:TDAC
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jun 2018 22:01
- Source
- TradingView